Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation

被引：4
|
作者：
Wachtell K. [1 ]
Devereux R.B. [1 ]
Lyle P.A. [1 ]
机构：
[1] Rigshospitalet, Department of Cardiology, The Heart Center, DK-2100 Copenhagen
来源：
Current Cardiology Reports | 2006年 / 8卷 / 5期
关键词：
Amiodarone; Enalapril; Losartan; Valsartan; Ramipril;
D O I：
10.1007/s11886-006-0075-1
中图分类号：
学科分类号：
摘要：
Atrial fibrillation, the most common cardiac arrhythmia in clinical practice, causes significant burden to patients and health care systems worldwide. Attention is being paid to prevention of atrial fibrillation using drugs that retard or prevent atrial fibrosis and arrhythmogenic remodeling, which lead to this arrhythmia. Agents that work through the renin-angiotensin-receptor system, the angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, are showing promise in animal and human studies. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：356 / 364
页数：8
相关论文
共 50 条
  • [1] Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
    Zeng, Yuanyuan
    Nie, Kelin
    Wallace, Kevin L.
    Li, Fangfang
    Zhang, Jing
    Li, Caizhen
    Wang, Yingying
    Zhang, Jiewen
    Wang, Jian
    Jiang, Chao
    [J]. Oxidative Medicine and Cellular Longevity, 2023, 2023
  • [2] Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation
    Anis, Rafik R.
    [J]. EXPERIMENTAL & CLINICAL CARDIOLOGY, 2009, 14 (01) : E1 - E7
  • [3] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
    Boos, CJ
    Lip, GYH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 890
  • [4] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers - Reply
    Healey, JS
    Morillo, CA
    Connolly, SJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 890 - 891
  • [5] Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or beta-blockers for treating hypertension
    Bisognano, John D.
    McLaughlin, Trent
    Roberts, Craig S.
    Tang, Simon S. K.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 579 - 585
  • [6] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
    Healey, JS
    Baranchuk, A
    Crystal, E
    Morillo, CA
    Garfinkle, M
    Yusuf, S
    Connolly, SJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) : 1832 - 1839
  • [7] Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis
    Baranchuk, AM
    Healey, J
    Crystal, E
    Yusuf, S
    Connolly, SJ
    [J]. CIRCULATION, 2004, 110 (17) : 461 - 461
  • [8] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    [J]. Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [9] Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis
    Raimondi, Sara
    Botteri, Edoardo
    Munzone, Elisabetta
    Cipolla, Carlo
    Rotmensz, Nicole
    DeCensi, Andrea
    Gandini, Sara
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 212 - 219
  • [10] Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice
    Barrios, Vivencio
    Coca, Antonio
    Escobar, Carlos
    Enrique, Rosa
    Miguel Rincon, Luis
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (02) : 159 - 166
12345